These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6363835)

  • 1. Monocylic beta-lactam antibiotics.
    Cimarusti CM; Sykes RB
    Med Res Rev; 1984; 4(1):1-24. PubMed ID: 6363835
    [No Abstract]   [Full Text] [Related]  

  • 2. The in vitro activity of the newer beta-lactam antibiotics against 124 strains of gram-negative bacilli.
    Dixson S; Andrew JH
    Pathology; 1985 Oct; 17(4):636-9. PubMed ID: 3938006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ways to overcome cephalosporinase-mediated beta-lactam resistance in Enterobacter cloacae.
    Then RL; Angehrn P
    Chemioterapia; 1985 Feb; 4(1):83-9. PubMed ID: 3872727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae?
    Marshall S; Hujer AM; Rojas LJ; Papp-Wallace KM; Humphries RM; Spellberg B; Hujer KM; Marshall EK; Rudin SD; Perez F; Wilson BM; Wasserman RB; Chikowski L; Paterson DL; Vila AJ; van Duin D; Kreiswirth BN; Chambers HF; Fowler VG; Jacobs MR; Pulse ME; Weiss WJ; Bonomo RA
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-lactamase stability and in vitro activity of aztreonam, with a comparison to 9 other beta-lactam antibiotics and gentamicin.
    Friis H; Prag J; Togsverd E; Benson MW
    Chemotherapy; 1986; 32(4):329-35. PubMed ID: 3488177
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Karlowsky JA; Kazmierczak KM; de Jonge BLM; Hackel MA; Sahm DF; Bradford PA
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SQ 26,776, a novel beta-lactam: an in-vitro comparison with other antimicrobial agents.
    Wise R; Andrews JM; Hancox J
    J Antimicrob Chemother; 1981 Dec; 8 Suppl E():39-47. PubMed ID: 6799481
    [No Abstract]   [Full Text] [Related]  

  • 8. Bactericidal and bacteriolytic activities of carumonam and its effect on bacterial morphology.
    Nakao M; Kondo M; Imada A
    J Antimicrob Chemother; 1986 Apr; 17(4):433-9. PubMed ID: 3086273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae isolates susceptible to third-generation cephalosporins or to aztreonam.
    Bert F; Bialek-Davenet S; Leflon-Guibout V; Noussair L; Nicolas-Chanoine MH
    Med Mal Infect; 2014 Feb; 44(2):76-8. PubMed ID: 24525113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aztreonam: the first monobactam.
    Sykes RB; Bonner DP
    Am J Med; 1985 Feb; 78(2A):2-10. PubMed ID: 3871589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tigemonam activity against clinical isolates of Enterobacteriaceae and Enterobacteriaceae with known mechanisms of resistance to beta-lactam antibiotics.
    Nélet F; Gutmann L; Kitzis MD; Acar JF
    J Antimicrob Chemother; 1989 Aug; 24(2):173-81. PubMed ID: 2676940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azthreonam: in vitro activity against urinary pathogens.
    Lang SD; McKenzie D
    Pathology; 1983 Apr; 15(2):159-60. PubMed ID: 6412200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The sensitivity to aztreonam and 10 other antibiotics of multiresistant enterobacteria.
    Koumentakou I; Kouskouni E; Kourkouli R; Papachristou E; Philippopoulou E; Kassimatis V; Papoulias G
    J Chemother; 1989 Jul; 1(4 Suppl):362-3. PubMed ID: 16312440
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibacterial activity of a monocyclic beta-lactam SQ 26,776.
    Neu HC; Labthavikul P
    J Antimicrob Chemother; 1981 Dec; 8 Suppl E():111-22. PubMed ID: 6799479
    [No Abstract]   [Full Text] [Related]  

  • 15. In-vitro activity of the monobactam Ro 17-2301 against clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa.
    Bremner DA
    J Antimicrob Chemother; 1985 Oct; 16(4):457-61. PubMed ID: 3934129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Background and rationale for revised clinical and laboratory standards institute interpretive criteria (Breakpoints) for Enterobacteriaceae and Pseudomonas aeruginosa: I. Cephalosporins and Aztreonam.
    Dudley MN; Ambrose PG; Bhavnani SM; Craig WA; Ferraro MJ; Jones RN;
    Clin Infect Dis; 2013 May; 56(9):1301-9. PubMed ID: 23334813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial properties of carumonam (Ro 17-2301, AMA-1080), a new sulfonated monocyclic beta-lactam antibiotic.
    Angehrn P
    Chemotherapy; 1985; 31(6):440-50. PubMed ID: 3935396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro activity of carumonam with gentamicin and other beta-lactam antimicrobials: a multicentric study.
    Martín-Luengo F; Baquero F; Cisterna R; García de Lomas J; García-Rodriguez J; Gobernado M; Gómez Lus R; Perea E; Piedrola G; Roy C
    Chemioterapia; 1987 Jun; 6(2 Suppl):115-6. PubMed ID: 3334551
    [No Abstract]   [Full Text] [Related]  

  • 19. Ceftazidime-Avibactam and Aztreonam, an Interesting Strategy To Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae and Pseudomonas aeruginosa.
    Davido B; Fellous L; Lawrence C; Maxime V; Rottman M; Dinh A
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630191
    [No Abstract]   [Full Text] [Related]  

  • 20.
    Kazmierczak KM; Bradford PA; Stone GG; de Jonge BLM; Sahm DF
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30249690
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.